封面
市場調查報告書
商品編碼
1198377

智能藥盒和藥瓶市場-增長、趨勢、COVID-19 影響和預測 (2023-2028)

Smart Pills Boxes and Bottles Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內(2023 年至 2028 年),智能藥盒和藥瓶市場預計將以 6.1% 左右的複合年增長率增長。

製藥公司是受 COVID-19 疫情直接影響的行業之一。 全球供應鏈中的缺口很大,包括對藥品、活性藥物成分、醫療用品和設備的採購、獲取和分銷的影響。 在大流行的早期階段,與臨床醫生對話和患者支持的傳統方法可能不再有效,導致製藥公司在這場危機中面臨災難性障礙,包括銷售損失。 在當前 COVID-19 流行的情況下,遠程醫療的需求量很大。 紐約市紀念斯隆凱特琳癌症中心 (MSKCC) 分子影像治療服務放射科主任 Heiko Schoder 說,2020 年 5 月,我們所有的護理服務、初診和復診都過渡到了遠程醫療。 這樣做是為了通過最大限度地減少患者和醫生之間的直接接觸來限制冠狀病毒的傳播。

推動市場增長的因素包括對個性化醫療和微創手術的需求不斷增長、慢性病和人口老齡化負擔日益加重,以及技術進步。 多種疾病,主要是心血管疾病、傳染病、糖尿病和腎臟相關並發症,在世界範圍內患病率很高。 因此,各個年齡段的各種疾病的患病率和全球負擔不斷增加,正在推動對智能醫療技術及其市場的需求。

在全球範圍內,癌症是導致死亡的主要原因之一。 該疾病在過去幾十年中經歷了顯著增長,預計在預測期內將穩步增長。 全球癌症觀察站估計,2020 年英國將有 457,960 例新確診癌症病例和 179,648 例癌症死亡病例。

根據英國心臟基金會於 2021 年 7 月發布的一份名為“英國概況”的報告,英國有 760 萬人患有心臟和循環系統疾病。 同一份文件還報告說,心臟和循環系統疾病每年在英國造成超過 160,000 人死亡,佔該地區所有死亡人數的四分之一。 此外,幾種生活方式疾病負擔的增加也有望推動市場。 產品發布也是推動市場增長的因素之一。 例如,2020 年 11 月,Pill Connect(前身為 Elucid mHealth)與連續創業者 Jonathan Milner、Catapult Ventures 和 Shallcross Partners 聯手在美國和歐洲商業推出電子智能藥瓶。510,000 英鎊(約合 9000 萬美元)日元)的資金收到。

智能藥盒和藥瓶市場趨勢

長期護理機構有望在智能藥盒和藥瓶市場佔據重要份額

長期護理機構是為殘障人士和老年患者提供一系列醫療和護理服務的醫療保健中心。 對長期護理的需求通常是嚴重的持續健康疾病或殘疾的結果。 長期護理需求可能會突然出現,例如在心髒病發作或中風之後。

世界上慢性病患病率上升和老年人口不斷增加需要多種治療方案並使用智能藥盒和瓶子使消費更容易,所研究的市場是每個細分市場背後的主要推動力 根據世界人口老齡化報告,美國65歲及以上人口預計到2030年將達到7084萬,高於2019年的5334萬,佔比將從2019年的16.2%上升到2030年的20.3% ,表明對市場的潛在積極影響。

老年人通常容易患骨關節炎、慢性阻塞性肺病、糖尿病、抑鬱症和癡呆症。 根據阿爾茨海默氏症協會的數據,2020 年美國約有 580 萬 65 歲以上的人患有阿爾茨海默氏病,預計到 2050 年這一數字將達到約 1380 萬。

此外,專注於開發技術先進的智能藥盒的市場參與者正在推動全球市場。 AdhereTech 是一家初創公司,專門為老年護理設施和長期護理設施開發智能無線藥瓶。

北美有望主導智能藥盒和藥瓶市場

北美主導市場主要是因為其先進的研發設施,主要位於美國和加拿大。 各種慢性病患病率上升也推動了該地區的市場增長。

在美國,癌症患者的數量正在顯著增加。 美國癌症協會估計,到 2021 年,美國將有 1,898,160 例新診斷的癌症和 608,570 例癌症死亡。

根據美國心髒病學會的數據,死於心血管疾病 (CVD) 的人數正在穩步上升,約佔全球所有死亡人數的三分之一,其中 2019 年男性死亡人數約為 960 萬,男性死亡人數約為 890 萬有婦女死亡的報導。 美國是 2019 年報告死亡人數最多的國家之一。 據聯合國報告,2015年美國65歲及以上人口有46986人,到2020年將達到55049人。 預計美國的老齡化速度將快於其他發達國家。 由於這些因素,未來市場可能會擴大。

智能藥盒和藥瓶市場競爭者分析

智能藥盒和藥瓶市場競爭激烈,由幾家主要參與者組成。 e-pill Medication Reminders、Group Medical Supply LLC、Medipense Inc.、Medminder Inc.、MedReady、PharmRight Corporation、PillDrill Inc. 和 Pillo Inc 等公司佔據了相當大的市場份額。

其他福利。

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 慢性病和人口老齡化負擔加重
    • 技術進步
  • 市場製約因素
    • 高成本問題
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分(基於價值的市場規模:百萬美元)

  • 按產品類型
    • 智能藥盒
    • 智能藥瓶
  • 根據指示
    • 癡呆症
    • 癌症管理
    • 糖尿病治療
    • 其他
  • 最終用戶
    • 家庭護理
    • 長期護理機構
    • 醫院
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 世界其他地區

第六章競爭格局

  • 公司簡介
    • e-pill Medication Reminders
    • Group Medical Supply LLC
    • Medipense Inc.
    • Medminder Inc.
    • MedReady
    • PharmRight Corporation
    • PillDrill Inc.
    • Pillo Inc.
    • Koninklijke Philips NV
    • Pill Connect
    • AdhereTech

第7章 市場機會今後動向

簡介目錄
Product Code: 69912

The Smart Pills Boxes and Bottles market studied is anticipated to witness a CAGR of nearly 6.1% during the forecast period (2023 - 2028).

Pharmaceutical companies are also among the industries that the COVID-19 outbreak has directly impacted. Gaps in the global supply chain, like an impact on the sourcing, acquisition, and distribution of pharmaceutical products, APIs, medical supplies, and equipment were substantial. Traditional methods of interacting with clinicians and supporting patients were longer viable during the initial phase of the pandemic, which resulted in pharmaceutical companies facing potentially catastrophic barriers, such as lower sales, during this time of crisis. In the current scenario with COVID-19, telemedicine is in high demand. According to Heiko Schoder, Chief of Molecular Imaging And Therapy Service, Department Of Radiology in Memorial Sloan Kettering Cancer Center (MSKCC), New York, in May 2020, their therapy operations, initial consultations, and all follow up consultations were shifted to telemedicine. This was done to minimize the direct contact between patients and doctors, thus controlling the spread of the coronavirus.

Certain factors that are driving the market growth include rising demand for personalized medicine and minimally invasive procedures, the growing burden of chronic disorders and the geriatric population, and technological advancements. The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and the burden globally drive the demand for smart medical technologies and their market.

Globally, cancer is one of the leading causes of death. The disease witnessed significant growth in the last few decades, and it is expected to grow well over the forecast period. According to the estimates of the Global Cancer Observatory, in 2020, there were an estimated 457,960 new cancer cases diagnosed and 179,648 cancer deaths in the United Kingdom.

According to the British Heart Foundation's Report titled UK Factsheet published in July 2021, there were 7.6 million people in the United Kingdom living with heart and circulatory diseases. Also, the same source reported that in the United Kingdom, heart and circulatory diseases cause more than 160,000 deaths each year, which is a quarter of all deaths in the region. Additionally, the increased burden of several lifestyle disorders is also expected to drive the market. Product launches are another factor in the growth of the market. For instance, in November 2020, Pill Connect, earlier known as Elucid mHealth, received GBP 510,000 funding from serial entrepreneur Jonathan Milner, Catapult Ventures, and Shallcross Partners for the commercial launch of its electronic smart pill bottle in the United States and Europe.

Smart Pills Boxes & Bottles Market Trends

Long-term Care Centers Expected to Hold Significant Share in the Smart Pills Boxes and Bottles Market

Long-term care facilities are the healthcare centers that provide a variety of services, including both medical and personal care, to people who are unable to live independently and for geriatric patients. People frequently need long-term care when they have a severe, continuing health ailment or disability. The necessity for long-term care can arise suddenly, such as after a heart attack or stroke.

The growing prevalence of chronic diseases, coupled with the increasing geriatric population globally, is the major factor driving the respective segment in the market studied as they require multiple treatment regimens, which will be easier to consume with the smart pill boxes and bottles. As per the World Population Ageing Report, in the United States, the number of people above 65 years of age is projected to reach 70.84 million by 2030 from 53.34 million in 2019, and the 65-and-older age group's share in the total population may rise from 16.2% in 2019 to 20.3%, by 2030, showing a positive impact on the market.

The older population is often susceptible to osteoarthritis, chronic obstructive pulmonary disease, diabetes, depression, and dementia. As per the data of the Alzheimer's Association, in 2020, about 5.8 million people aged 65 years and above are suffering from Alzheimer's dementia in the United States, and this number is expected to reach around 13.8 million in 2050.

Market players focusing on developing technologically advanced smart pill boxes are also driving the market globally. AdhereTech is a startup specially involved in developing smart wireless pill bottles for senior assisted living and long-term care centers.

North America Expected to Dominate the Smart Pills Boxes and Bottles Market

North America dominates the market primarily due to the advanced research and development facilities, mainly across the United States and Canada. The rising prevalence of various chronic conditions is also fueling the market growth across the region.

The United States has witnessed a considerable rise in the number of cancer patients. According to the estimates of the American Cancer Society, in 2021, there were an estimated 1,898,160 new cancer cases diagnosed and 608,570 cancer deaths in the United States.

As per the American College of Cardiology, the number of people dying from cardiovascular disease (CVD) is steadily rising, which includes around one-third of all deaths globally, of which around 9.6 million deaths were reported among men, and 8.9 million deaths were reported among women in 2019. The United States was among one the countries to report the highest number of deaths in 2019. According to a United Nations report, there were 55,049 people aged 65 years and above in 2020 compared to 46,986 people in 2015 in the United States. The United States is expected to experience an accelerated rate of the aging population as compared to other developed countries. Due to these factors, the market is likely to grow in the future.

Smart Pills Boxes & Bottles Market Competitor Analysis

The Smart Pills Boxes and Bottles market is competitive and consists of a few major players. Companies like e-pill Medication Reminders, Group Medical Supply LLC, Medipense Inc., Medminder Inc., MedReady, PharmRight Corporation, PillDrill Inc., and Pillo Inc. hold substantial market share.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Chronic Disorders and Geriatric Population
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Smart Pill Boxes
    • 5.1.2 Smart Pill Bottles
  • 5.2 By Indication
    • 5.2.1 Dementia
    • 5.2.2 Cancer Management
    • 5.2.3 Diabetes Care
    • 5.2.4 Other Indications
  • 5.3 By End User
    • 5.3.1 Home Care Settings
    • 5.3.2 Long Term Care Centers
    • 5.3.3 Hospitals
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 e-pill Medication Reminders
    • 6.1.2 Group Medical Supply LLC
    • 6.1.3 Medipense Inc.
    • 6.1.4 Medminder Inc.
    • 6.1.5 MedReady
    • 6.1.6 PharmRight Corporation
    • 6.1.7 PillDrill Inc.
    • 6.1.8 Pillo Inc.
    • 6.1.9 Koninklijke Philips NV
    • 6.1.10 Pill Connect
    • 6.1.11 AdhereTech

7 MARKET OPPORTUNITIES AND FUTURE TRENDS